Structural insights into the orthosteric inhibition of P2X receptors by non-ATP-analog antagonists

Danqi Sheng,Chenxi Yue,Fei Jin,Yao Wang,Muneyoshi Ichikawa,Ye Yu,Chang-Run Guo,Motoyuki Hattori

DOI: https://doi.org/10.1101/2023.09.15.558037

2024-02-07

Abstract:P2X receptors are extracellular ATP-gated ion channels that form homo-or heterotrimers and consist of seven subtypes. They are expressed in various tissues, including neuronal and nonneuronal cells, and play critical roles in physiological processes such as neurotransmission, inflammation, pain, and cancer. As a result, P2X receptors have attracted considerable interest as drug targets, and various competitive inhibitors have been developed. However, although several P2X receptor structures from different subtypes have been reported, the limited structural information of P2X receptors in complex with competitive antagonists hampers the understanding of orthosteric inhibition, hindering the further design and optimization of those antagonists for drug discovery. Here, we determined the cryo-EM structures of the mammalian P2X7 receptor in complex with two classical competitive antagonists of pyridoxal-5’-phosphate derivatives, PPNDS and PPADS, at 3.3 and 3.6 Å resolution, respectively, and performed structure-based mutational analysis by patch-clamp recording as well as MD simulations. Our structures revealed the orthosteric site for PPADS/PPNDS, and structural comparison with the previously reported apo-and ATP-bound structures showed how PPADS/PPNDS binding inhibits the conformational changes associated with channel activation. In addition, structure-based mutational analysis identified key residues involved in the PPNDS sensitivity of P2X1 and P2X3, which are known to have higher affinity for PPADS/PPNDS than other P2X subtypes. Overall, our work provides structural insights into the orthosteric inhibition and subtype specificity of P2X receptors by the classical P2X antagonists, pyridoxal-5’-phosphate derivatives, thereby facilitating the rational design of novel competitive antagonists for P2X receptors.

Biophysics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about the specific mechanism of how P2X receptors are orthosterically inhibited by non - ATP - analogue antagonists such as PPADS and PPNDS. P2X receptors are a class of cation channels activated by extracellular ATP. They are expressed in multiple tissues and are involved in various physiological processes such as neurotransmission, inflammation, pain, and cancer. Therefore, P2X receptors have received extensive attention as drug targets, and various competitive inhibitors have been developed. However, due to the lack of structural information on P2X receptor - competitive antagonist complexes, the understanding of orthosteric inhibition is limited, which hinders the design and optimization of these antagonists for drug discovery.

Specifically, this study revealed the orthosteric binding sites of these antagonists by determining the cryo - EM structures of mammalian P2X7 receptor complexes with two classic antagonists, PPADS and PPNDS, and by comparing with the previously reported apo - and ATP - bound P2X7 receptor structures, showed how PPADS/PPNDS binding inhibits the conformational changes associated with channel activation. In addition, structure - based mutational analysis identified key residues involved in the sensitivity of P2X1 and P2X3 receptors to PPNDS, which are known to have a higher affinity for PPADS/PPNDS.

Overall, this work provides structural insights into P2X receptor orthosteric inhibition and its subtype - specificity, facilitating the rational design of novel P2X receptor competitive antagonists.